About EnCor Biotechnology
EnCor Biotechnology is a Healthcare company based in Gainesville (United States) founded in 1999 by Gerry Shaw. It specializes in manufacturing and research for antibody development. It operates on a B2B model. Its chief executive, as recorded, is Gerry Shaw. Its focus areas include Biotechnology, Research and Development and Antibody Manufacturing. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
EnCor Biotechnology operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, research and development, and antibody manufacturing. Specializes in manufacturing and research for antibody development. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Gainesville, United States
- Founders Gerry Shaw
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website encorbio.com
- Social LinkedIn X Facebook YouTube
Apps and channels of EnCor Biotechnology
its YouTube channel Florida High Tech Corridor has 62 subscribers and 30 videos.
Videos from EnCor Biotechnology
The most watched videos on EnCor Biotechnology's YouTube channel, Florida High Tech Corridor (62 subscribers). Click a video to play it here.
More on Florida High Tech Corridor.
People of EnCor Biotechnology
1 people are tracked at EnCor Biotechnology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Gerry Shaw | Founder, CEO | Leadership |
Complete people profiles for EnCor Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of EnCor Biotechnology
EnCor Biotechnology has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of EnCor Biotechnology
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EnCor Biotechnology
Websites that share an audience with EnCor Biotechnology (encorbio.com).
Websites whose visitors overlap most with EnCor Biotechnology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lakepharma.com | 93% | View details | |||
| morphosys.com | 89% | View details | |||
| epitomics.com | 80% | View details | |||
| hypromatrix.com | 78% | View details | |||
| mesoscale.com | 72% | 55.1K | #561,007 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for EnCor Biotechnology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as EnCor Biotechnology (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EnCor Biotechnology
EnCor Biotechnology was founded in 1999.
EnCor Biotechnology is headquartered in Gainesville, United States.
Gerry Shaw is the CEO of EnCor Biotechnology, as recorded in our data. They have also founded this company.
EnCor Biotechnology operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, research and development, and antibody manufacturing. Specializes in manufacturing and research for antibody development. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
EnCor Biotechnology's top competitors include GenScript, Epitomics and Vector Laboratories.